Major stock indexes closed higher on Friday, driven by corporate earnings reports from tech firms like Alphabet and Amazon.

A fresh crop of shareholder proposals that would have once been unremarkable are now a closely-watched battlefront in the war ...

The Pharmaceutical ... 56% of Black Americans and 60% of Hispanic Americans surveyed were subject to utilisation management practices, compared to just 36% of white Americans.

and 1.8 times higher among black compared to white adults. "This initiative will give us better insights into the cardiovascular health of New Yorkers in an effort to identify the most pressing ...

Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...

Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...

With yet another quarter where Pfizer handily beat consensus earnings expectations, it’s even more clear that CEO Albert Bourla is already well on his way toward getting Pfizer back on track ...

Germany’s Merck KGaA is in advanced talks to acquire ... A SpringWorks spokesperson told Fierce Pharma the company "does not comment on market rumors or speculation.” The development comes ...

Kineta has found a new home for deals with Genentech and Merck & Co. Tidying up the portfolio ahead of its merger with TuHURA Biosciences, the biotech has agreed to sell the deals to an investment ...

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of ...

WEST LAFAYETTE, Ind. — Purdue University, in collaboration with Eli Lilly and Company and Merck & Co. Inc., announced Friday (Jan. 17) the launch of the Young Institute Pharmaceutical Manufacturing ...

We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Long-Term Pick. In this article, we will summarize ...